Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : SNYNF    crawled date : 2022 - 04 - 19    save search

Sionna Therapeutics Launches with $111 Million Series B Financing to Advance Pipeline of Novel Small Molecules with the Potential to Fully Restore CFTR Function in Cystic Fibrosis
Published: 2022-04-19 (Crawled : 22:00) - biospace.com/
SNY | News | $47.1 -1.24% 260K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

fibrosis therapeutics potential cystic fibrosis
Ligand to Report First Quarter Financial Results on May 4
Published: 2022-04-19 (Crawled : 22:00) - biospace.com/
SNY | News | $47.1 -1.24% 260K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%
LGND | $69.31 -0.83% 14K twitter stocktwits trandingview |
Health Technology
| | O: 0.87% H: 1.96% C: 1.58%

report results
Fueled by $111 Million, Sionna Therapeutics Takes Aim at Cystic Fibrosis
Published: 2022-04-19 (Crawled : 20:00) - biospace.com/
SNY | News | $47.1 -1.24% 260K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

fibrosis therapeutics cystic fibrosis
Oncomatryx Announces a €15 Million Capital Increase to Conduct Clinical Trials Against the Tumor Micro-environment
Published: 2022-04-19 (Crawled : 18:00) - biospace.com/
SNY | News | $47.1 -1.24% 260K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

trials trial
AUM Biosciences and HANDOK Presented Phase 1 Data for AUM-601 at ESMO Targeted Anticancer Therapies Congress 2022
Published: 2022-04-19 (Crawled : 15:00) - biospace.com/
SNY | News | $47.1 -1.24% 260K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

aum-601 phase 1 therapy
Cystic Fibrosis Foundation Invests $5 Million in Sionna Therapeutics to Develop New CFTR Modulator Therapy
Published: 2022-04-19 (Crawled : 14:20) - biospace.com/
SNY | News | $47.1 -1.24% 260K twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%

fibrosis therapeutics therapy cystic fibrosis
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M twitter stocktwits trandingview |
Consumer Services

CZOO | $11.685 134.17% 7.6M twitter stocktwits trandingview |

BOF | $1.93 64.96% 55M twitter stocktwits trandingview |

AMST | $3.14 57.0% 59M twitter stocktwits trandingview |
Technology Services

TROO | $1.57 44.04% 2.8M twitter stocktwits trandingview |
Manufacturing

RILY | $30.87 42.13% 7.8M twitter stocktwits trandingview |
Finance

LICN | $0.76 35.71% 6.2M twitter stocktwits trandingview |

WHLM | $6.61 30.12% 400K twitter stocktwits trandingview |
Commercial Services

MULN | News | $3.53 29.3% 4.8M twitter stocktwits trandingview |
Information

RBBN 4 | $3.26 26.85% 1.2M twitter stocktwits trandingview |
Electronic Technology


Your saved searches
Save your searches and get alerts when important news are released.